VICARIOUS SURGICAL INC (RBOT)
US92561V1098 - Common Stock
ChartMill assigns a Buy % Consensus number of 76% to RBOT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.05. This target is 290.36% above the current price.
RBOT was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about RBOT.
In the previous month the buy percentage consensus was at a similar level.
RBOT was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-05 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-12-04 | Morgan Stanley | Initiate | Equal-Weight |
| 2023-11-14 | BTIG | Downgrade | Buy -> Neutral |
| 2023-11-14 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2023-05-31 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2022-07-18 | BTIG | Maintains | Buy |
| 2022-05-10 | Piper Sandler | Maintains | Neutral |
| 2022-03-04 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022-01-07 | Credit Suisse | Initiate | Outperform |
| 2021-12-07 | Cowen & Co. | Initiate | Outperform |
| 2021-11-05 | Canaccord Genuity | Initiate | Buy |
| 2021-10-18 | BTIG | Initiate | Buy |
| 2021-10-07 | Piper Sandler | Initiate | Overweight |